Aramark (ARMK) 2025 Conference June 05, 2025 11:25 AM ET Speaker0 All right. Cool. All right. Hi, everyone. Welcome to the next session of Baird's Global Consumer Technology and Services Conference. We're really happy to have everyone join us. I'm Andy Wittmann. I cover the facility services stocks here at Baird. And really happy to be joined again this year by Aramark. Jim Tarantulo is up on stage with me. He's the company's CFO. We have about a half an hour to go through the company, the story. I'm going ...

Compass Therapeutics (CMPX) 2025 Conference June 05, 2025 11:05 AM ET Speaker0 And one of the biotech analysts at Jefferies. It's with great pleasure I'd like to welcome Tom Schutz, the CEO of Compass Therapeutics. Thanks so much for joining us today, Tom. Speaker1 Thanks, Maury. Thanks for inviting us. Appreciate it. Speaker0 And we're gonna do fireside chat format. So maybe for those who are new to this story, if you can give a one minute intro to Compass. Speaker1 Sure, thanks. Compass, we're based in Bo ...

Hologic (HOLX) 2025 Conference June 05, 2025 11:05 AM ET Speaker0 Okay. We're gonna kick it off. I'm Tycho Peterson from the life science team. It's my pleasure to introduce Hologic. Thank you for joining us, Colleen. Speaker1 Thanks for having me. Great to be here. Speaker0 I'm I'm gonna go to the elephant in the room to start. Just on the, Financial Times article, any comments you're willing to make, just on, you know, some of the noise that's been out there in the market? Speaker1 Yeah. Unfortunately, Ty ...

Terns Pharmaceuticals (TERN) 2025 Conference June 05, 2025 11:05 AM ET Speaker0 All right, welcome everybody. I have the pleasure of hosting Terns Pharmaceuticals here. My name is Zaki Malvi. I'm standing in for Amy Lee. We're all associates on Akash Tewari's team. So I have Amy Burrows and Emil Koryakos from Trans Pharmaceuticals. We're excited to host them. I'll let you guys give some opening remarks and then we'll go into the Q and A. Speaker1 Great. Thank you so much to Zaki, to you, to Akash's whole te ...

Immunocore Holdings (IMCR) 2025 Conference June 05, 2025 11:05 AM ET Speaker0 Welcome everyone to the next session. I'm Michael Yee, Senior Biotechnology Analyst at Jefferies and I'm Speaker1 very pleased to have members of the Immunocor team up here with us. David Berman, Chief Scientific Officer and Ralph Torbay, the Chief Commercial Officer. Fantastic duo bunch because we're going to talk about revenues and sales and an approved drug in the commercial side. And, we're also going to Speaker0 talk with Dav ...

TELA Bio (TELA) 2025 Conference June 05, 2025 11:05 AM ET Speaker0 All right. We can kick this off. Hello, everyone. My name is Mike Sarcone. I'm an analyst on the US Medical Supplies and Devices team. And this is day two of the Jefferies twenty twenty five New York Health Care Conference. This is a fireside chat with TeleBio. And from the company, we have Tony Koblish, founder, president, and CEO and Roberto Kuka, chief operating officer and CFO. Gentlemen, thank you for joining us today. Speaker1 Thank yo ...

Hayward (HAYW) FY Conference June 05, 2025 11:00 AM ET Speaker0 Alright. Hello, everyone. Good morning. Welcome to the Hayward presentation. Sorry, I'm late. A little snafu with the schedule. I'm Ryan Merkel. I cover Building Products at William Blair. Before we begin, need to remind you that a complete list of disclosures and conflicts of interest is available on our website. With us today is Kevin Holleran, President and CEO Ivey and Jones, CFO and Stuart Baker, Vice President of Business Development. For ...

CoreCivic (CXW) Conference June 05, 2025 11:00 AM ET Speaker0 Good morning, and welcome to the Noble Capital Markets virtual equity conference. I am Joe Gomes, managing director and senior analyst at Noble Capital. Today, I have the pleasure of introducing CoreCivic Inc. Following the presentation, we have some time for q and a. CoreCivic is a diversified government solutions company with the scale and experience needed to solve tough government challenges in flexible cost effective ways. With us today from ...

Confluent (CFLT) FY Conference June 05, 2025 11:00 AM ET Speaker0 All right. Good morning, everyone. Thanks for being here on the third day of the conference. I'm Jason Ader with William Blair. I'm pleased to introduce Rohan Subram, CFO of Confluent. Before we begin, I'm required to inform you that a complete list of research exposures or potential conflicts of interest is available on our website at williamblair.com. With that out the way, Rohan, thanks for being here. And, we're gonna just do the fireside ...

Summary of Asana's Conference Call Company Overview - **Company**: Asana - **Industry**: Software, specifically in the Collaborative Work Management (CWM) space - **Key Personnel**: Sonali Parikh (CFO), Aziz Meghji (FP&A) Core Points and Arguments 1. **Product Leadership and Growth Opportunity**: Asana is positioned as a leader in the CWM category with significant growth potential, particularly in enterprise markets, driven by innovation and a strong product offering [5][6][7] 2. **AI Studio Launch**: The recent launch of AI Studio is expected to differentiate Asana from competitors, enhancing its product capabilities through context-aware AI [6][15][21] 3. **Competitive Landscape**: Asana competes in a fragmented market but differentiates itself through its work graph, which integrates AI capabilities, allowing for cross-functional collaboration [15][19][20] 4. **Large Contract Win**: Asana secured a landmark $100 million Total Contract Value (TCV) deal, marking a significant achievement in scalability and enterprise adoption [30][34] 5. **Upsell Opportunities**: The large contract does not include AI Studio or service plans, indicating potential for future upselling and expansion within the client [33][36] 6. **Enterprise Go-to-Market Strategy**: Approximately 60% of Asana's business comes from corporate and enterprise clients, with plans to enhance channel partnerships to drive growth [41][42] 7. **Operating Efficiency**: Asana has improved its operating margin from -9% to over 4%, with a focus on maintaining high gross margins (90%) while driving growth [55][56] 8. **AI Strategy Importance**: The AI roadmap is a critical differentiator in enterprise negotiations, with a focus on making AI adoption frictionless for customers [24][25] 9. **Future Outlook**: Asana aims to establish itself as a leader in AI collaboration tools and improve net retention rates through focused initiatives [69][72] Additional Important Insights 1. **Cultural Impact of Leadership Changes**: Dustin Moskovitz is transitioning to a more strategic role focused on AI, which is expected to enhance Asana's vision and operational effectiveness [63][64] 2. **Channel Growth Potential**: There is a significant opportunity to increase revenue from channel partnerships, which currently represent a small percentage of overall ARR [42][44] 3. **Focus on Retention**: Asana is prioritizing improvements in net retention rates, particularly in its monthly business segment, which has historically contributed to churn [72][73] 4. **Investment in Lower-Cost Geographies**: The company is shifting hiring strategies to include lower-cost regions, which is expected to positively impact overall cost structure [61][62] This summary encapsulates the key points discussed during the conference call, highlighting Asana's strategic direction, competitive advantages, and future growth opportunities.